Integra LifeSciences Initiates Full Rollout of New Wrist Arthroplasty System

Integra LifeSciences has made the full commercial release of its Freedom wrist arthroplasty system in the United States. The system, which is used in the treatment of wrist arthritis, has been successfully implanted in a limited release in 21 patients during the summer months.

“The design features of the Freedom Wrist Arthroplasty System provide a major advancement in the treatment of more active patients with advanced wrist arthritis,” said designing surgeon Brian Adams, M.D., Baylor College of Medicine in Houston, Texas. “This unique system, including a more anatomic design and better bone fixation, offers a distinct alternative for patients to achieve pain relief while simultaneously maintaining desired wrist motion.”

The implant advanced implant design and enhanced instrumentation to aid in efficient and potentially more reproducible surgical results, according to the company.

“The Integra Freedom wrist arthroplasty System complements and expands our upper extremity portfolio and offers our surgeons an advanced anatomic solution for wrist arthroplasty procedures. We believe this product is a natural addition to our portfolio and will add to our success and growth in this market,” said Mark Augusti, president of Integra’s Orthopedics and Tissue Technologies division. “This is an excellent example of Integra’s commitment to design products that help limit uncertainty for surgeons.”

The system will be on display at the 69th Annual Meeting of the American Society for Surgery of the Hand in Boston, Mass., from Sept. 18-20, 2014. During the meeting, Adams and Randy Bindra, M.D., will conduct a demonstration of the system and sharie their experience in an industry forum on Sept. 19 at 12:00 p.m.

Plainsboro, N.J.-based Integra LifeSciences makes technology for orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery.